SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-000708
Filing Date
2018-02-09
Accepted
2018-02-09 17:23:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2234501z424b5.htm 424B5 439319
2 G758474.JPG g758474.jpg GRAPHIC 10088
3 G11949.JPG g11949.jpg GRAPHIC 12536
  Complete submission text file 0001047469-18-000708.txt   471760
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-220315 | Film No.: 18593020
SIC: 2834 Pharmaceutical Preparations